Best Oral BPC-157 Providers in 2026: Ranked and Reviewed
No form of BPC-157 is FDA-approved, and no oral form has been tested for absorption in people. An interim HHS policy of October 28, 2026 covers compounding of BPC-157 acetate by state-licensed 503A pharmacies, capsules included: HHS writes that it does not intend to take enforcement action against that work when a list of conditions is met. One condition is for pills alone. The pharmacy should hold records showing that its exact capsule gets enough peptide into the bloodstream of a person. This board lists sellers whose own page, read on October 30, 2026, offers BPC-157 as a single ingredient, by prescription, with an oral capsule among the forms. A capsule from a supplement store is outside the policy.
6 providers compared
New to BPC-157? Read our full BPC-157 guide — evidence, dosing, safety and side effects.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
6 oral BPC-157 providers compared · independently scored against our six-factor methodology.
Quick Picks
Oral BPC-157: what the record shows
Each point below comes from the primary source cited beside it, and each links the GW article that covers it at length.
Condition 8
the policy's rule for oral forms
For any peptide made into a pill, HHS expects the pharmacy to keep records proving that the very formulation a patient receives is absorbed well enough when swallowed, measured in people. It never says how much absorption counts as enough.[12]
BPC-157 capsules →No human data
on BPC-157 absorbed by mouth
FDA's reviewers, briefing its compounding advisory committee in July 2026, found no human pharmacokinetic data for BPC-157 taken orally, or by any of the other routes they looked at.[13]
What FDA said about BPC-157 →One ingredient
no blends, no stacks
The policy covers single-ingredient products only. A capsule that pairs BPC-157 with TB-500, KPV or a probiotic falls outside it, so a seller whose only capsule is a blend is not on this board.[12]
Why blends are excluded →
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
single-ingredient BPC-157 by prescription (injection, oral)
From /moCheck pricingCoverage50 statesMedicationsBPC-157EpitalonMOTS-cSemaxTB-500 single-ingredient BPC-157 by prescription (subcutaneous injection, intramuscular injection, topical, oral)
From /moCheck pricingCoverage45 states + DCMedicationsBPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500- Best Budget
single-ingredient BPC-157 by prescription (subcutaneous injection, oral)
From /mo$116CoverageCheck intakeMedicationsBPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500
Show 3 moreShow fewer
single-ingredient BPC-157 by prescription (subcutaneous injection, oral)
From /moCheck pricingCoverage27 states + DCMedicationsBPC-157CJC-1295 / IpamorelinEpitalonGHK-CuGlutathioneGonadorelinIpamorelinKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelin- Nationwide Coverage
single-ingredient BPC-157 by prescription (injection, oral)
From /moCheck pricingCoverage50 statesMedications5-Amino-1MQBPC-157CJC-1295 / IpamorelinDSIPGHK-CuGlutathioneKPVMOTS-cNAD+PT-141SelankSemaxSermorelinTB-500Tesamorelin single-ingredient BPC-157 by prescription (injection, oral)
From /moCheck pricingCoverage47 statesMedications5-Amino-1MQAOD-9604BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinKPVNAD+PT-141SermorelinTB-500Tesamorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick single-ingredient BPC-157 by prescription (injection, oral) | Check pricing | BPC-157EpitalonMOTS-cSemaxTB-500 | 50 states | Visit → | |
 single-ingredient BPC-157 by prescription (subcutaneous injection, intramuscular injection, topical, oral) | Check pricing | BPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500 | 45 states + DC | Visit → | |
Best Budget single-ingredient BPC-157 by prescription (subcutaneous injection, oral) | $116 | BPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500 | Check intake | Visit → | |
 single-ingredient BPC-157 by prescription (subcutaneous injection, oral) | Check pricing | BPC-157CJC-1295 / IpamorelinEpitalonGHK-CuGlutathioneGonadorelinIpamorelinKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelin | 27 states + DC | Visit → | |
Nationwide Coverage single-ingredient BPC-157 by prescription (injection, oral) | Check pricing | 5-Amino-1MQBPC-157CJC-1295 / IpamorelinDSIPGHK-CuGlutathioneKPVMOTS-cNAD+PT-141SelankSemaxSermorelinTB-500Tesamorelin | 50 states | Visit → | |
 single-ingredient BPC-157 by prescription (injection, oral) | Check pricing | 5-Amino-1MQAOD-9604BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinKPVNAD+PT-141SermorelinTB-500Tesamorelin | 47 states | Visit → |
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What this ranking checks
The HHS policy dated October 28, 2026 is interim enforcement discretion, and HHS's Federal Register notice of October 30, 2026 calls it a draft that is not binding. It does not approve BPC-157 or add it to the 503A bulks list, it covers 503A pharmacies, federal facilities and licensed physicians only, and HHS can narrow or withdraw it. For BPC-157 acetate the covered routes are subcutaneous, intramuscular, oral and topical. Its other conditions apply to a capsule as much as to a vial: a patient-specific prescription, BPC-157 as the only active ingredient, raw powder from an FDA-registered plant with a certificate of analysis, adverse events reported to FDA MedWatch, and a label saying the product is compounded and not for resale.
What our ranking checks: that the seller's own website, read on November 5, 2026, offers BPC-157 as a single ingredient, by prescription, and sells an oral capsule. Sellers whose capsules are blends, or who sell BPC-157 without a prescription step, are not ranked.
What no website read can show: whether the pharmacy holds the oral absorption documentation the policy expects, which 503A pharmacy fills the prescription, the certificate of analysis, and the label. Ask the seller for those before you pay. Being ranked here is not a finding that a seller meets the policy.
What each seller’s own page showed on November 5, 2026
- AmbleRoute: injection, oralPrice as listed: $249/month
- New TidesRoute: subcutaneous injection, intramuscular injection, topical, oralPrice as listed: not published
- Scripts Rx DirectRoute: subcutaneous injection, oralPrice as listed: Injection 3 mg/mL: $169 for 1 month, $459 for 3 months ($153/mo); oral capsules 500 mcg: $129 for 1 month, $349 for 3 months ($116/mo)
- RxPepsDirectRoute: subcutaneous injection, oralPrice as listed: $80 per 5mL vial (15mg total); oral capsules $2.50/cap (500mcg)
- HealthClinic MDRoute: injection, oralPrice as listed: not published
- Viking Alternative MedicineRoute: injection, oralPrice as listed: not published
Detailed Reviews
About the prices below: every dollar figure inside these provider summaries belongs to that clinic’s GLP‑1 weight-loss program. None is a BPC-157 price. For BPC-157 itself, read the price each seller’s own page listed, under “What this ranking checks” above. “Check pricing” in the tables means we hold no monthly figure for that seller that compares like for like, since many quote per vial, per capsule or per multi-month protocol.
Amble
Best for: single-ingredient BPC-157 by prescription (injection, oral)
Amble Health, Inc. sells compounded semaglutide and tirzepatide online at one price for every dose, with supplies and shipping included. Semaglutide is $179 for a 1-month plan and tirzepatide $329, and the first month is $50 off. Longer plans cut the monthly rate to as low as $135 and $235, but they are charged in full up front and cannot be refunded once the order reaches the pharmacy.
Score Breakdown
Pros
- ✓Semaglutide costs $179 a month, 10% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to Amble
Cons
- ✗Tirzepatide costs $329 a month, 22% above the $269 median for compounded tirzepatide across the sellers we compare
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
New Tides
Best for: single-ingredient BPC-157 by prescription (subcutaneous injection, intramuscular injection, topical, oral)
New Tides is a physician-led telehealth practice that prescribes compounded semaglutide and tirzepatide and may also prescribe nine peptides, including the six named in the October 2026 HHS peptide policy. Nothing is charged at sign-up: the card you save is charged only when a physician sends a prescription, and there is no subscription. Semaglutide is $200 and tirzepatide $250 per prescription, the same at every dose, with the physician visit, medication and shipping included.
Score Breakdown
Pros
- ✓Semaglutide costs $200 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $250 a month, 7% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves 45 states and DC
- ✓We found no FDA warning letters issued to New Tides
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Scripts Rx Direct
Best for: single-ingredient BPC-157 by prescription (subcutaneous injection, oral)
Score breakdown, pros and cons
Scripts Rx Direct is an online clinic that prescribes compounded semaglutide and tirzepatide and sells a catalog of compounded peptides, including all six named in the October 2026 HHS peptide policy, plus NAD+, sermorelin and glutathione. Every listing shows its price before checkout, and a clinician licensed in your state reviews an intake that follows payment. One-month offers list semaglutide at $200 and tirzepatide at $247.
Score Breakdown
Pros
- ✓Semaglutide costs $200 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $247 a month, 8% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes clinician visits
- ✓We found no FDA warning letters issued to Scripts Rx Direct
Cons
- ✗Confirm it serves your state before you start the intake
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
RxPepsDirect
Best for: single-ingredient BPC-157 by prescription (subcutaneous injection, oral)
Score breakdown, pros and cons
Pricing is per vial: semaglutide/B12 from $25 a vial and tirzepatide/B12 from $45, after a $39 asynchronous online medical review, with no subscription required. A licensed 503A pharmacy in Texas compounds and dispenses. Prescriptions are written by licensed nurse practitioners and physician assistants, with Dr. Jonathan Snipes, MD as medical director. FedEx overnight shipping is a $15 flat pharmacy fee. Peptide RX LLC operates the brand in 28 states and DC.
Score Breakdown
Pros
- ✓Semaglutide costs $64 a month, 68% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $84 a month, 69% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓The monthly price includes the medication and clinician visits
- ✓We found no FDA warning letters issued to RxPepsDirect
Cons
- ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- ✗Not included in the monthly price: shipping, lab work, coaching
- ✗Serves only 27 states and DC, so check that yours is one of them
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
HealthClinic MD
Best for: single-ingredient BPC-157 by prescription (injection, oral)
Score breakdown, pros and cons
HealthClinic MD is a family-owned telehealth practice in Pittsburgh that prescribes compounded semaglutide and tirzepatide, hormone therapy and a long list of peptides. The first consultation and follow-ups are free, but no medication price is published: a plan and invoice appear in the patient portal only after a provider approves treatment, and the practice bills a recurring subscription fee set at sign-up.
Score Breakdown
Pros
- ✓The monthly price includes the medication and clinician visits
- ✓Serves all 50 states
- ✓We found no FDA warning letters issued to HealthClinic MD
Cons
- ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Related research
The board shows who sells a prescription capsule. These pages cover the evidence, the policy's conditions, and how a pharmacy product differs from a research chemical.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 12.HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, with Appendices A and B (October 28, 2026)— U.S. Department of Health and Human Services.
- 13.FDA Briefing Document, Pharmacy Compounding Advisory Committee, July 23-24, 2026: BPC-157— U.S. Food and Drug Administration.